Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis

Purpose The current study investigated the potential therapeutic efficiency of atosiban, an oxytocin receptor antagonist, in an experimental endometriosis model.

Endometriosis was surgically induced in 35 female rats during estrus. Four weeks after this procedure, relaparotomy was performed. The viability and dimensions of the endometriosis foci were recorded. Rats were then randomly divided into three groups. In the first group (n = 8), a daily dose of 0.2 ml 0.9 % NaCl was injected intraperitoneally (i.p.) (control cases). In the second and third groups (n = 8 and n = 8), 0.5 mg/kg/day i.p. atosiban and 1 mg/day i.p. diltiazem were given, respectively. At the end of the treatment, laparotomy was performed, and the dimensions of the endometriosis foci were recorded. The endometrial implants were processed for histological and immunohistochemical studies. The volumes of endometriotic implants were measured, and immunohistochemical analyses were performed, and compared between the groups.

After the treatment with atosiban, volumes of endometriotic implants decreased significantly. Proliferating cell nuclear antigen expression levels were significantly reduced in the atosiban and diltiazem groups compared with the control group.

In a rat endometriosis model, atosiban, an agent used for the first time for the medical treatment of endometriosis, has shown significant therapeutic efficiency. Similar content being viewed by others

Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M et al (2002) Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 78(4):665–678 Giudice LC, Kao LC (2004) Endometriosis. Lancet 13–19;364(9447):1789–1799 Matarese G, De Placido G, Nikas Y, Alviggi C (2003) Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 9(5):223–228 Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M et al (2008) Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 23(12):2701 Celik O, Hascalik S, Elter K, Tagluk ME, Gurates B, Aydin NE (2008) Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod 23(11):2458–2465 Jacobson TZ (2011) Potential cures for endometriosis. Ann N Y Acad Sci 1221:70–74 Asselin E, Goff AK, Bergeron H, Fortier MA (1996) Influence of sex steroids on the production of prostaglandins F2 alpha and E2 and response to oxytocin in cultured epithelial and stromal cells of the bovine endometrium. Biol Reprod 54(2):371–379 Danet-Desnoyers G, Wetzels C, Thatcher WW (1994) Natural and recombinant bovine interferon tau regulate basal and oxytocin-induced secretion of prostaglandins F2 alpha and E2 by epithelial cells and stromal cells in the endometrium. Reprod Fertil Dev 6(2):193–202 Mechsner S, Bartley J, Loddenkemper C, Salomon DS, Starzinski-Powitz A, Ebert AD (2005) Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril 83:1220–1231 Bussolati G, Cassoni P (2001) Editorial: the oxytocin/oxytocin receptor system-expect the unexpected. Endocrinology 142(4):1377–1379 Zeitoun KM, Bulun SE (1999) Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 72(6):961–969 Gross GH (1977) A technique for sustained synchronization of hamster estrous cycles by hormonal means. Horm Behav 9:23–31 Vernon MW, Wilson EA (1985) Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44:684–694 Kannan V, Gadamsetty D, Rose M, Maria S, Mustafa I, Khedkar A et al (2010) Quantitative determination of oxytocin receptor antagonist atosiban in rat plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1;878(15–16):1069–1076 Downing SJ, Edwards D, Hollingsworth M (1987) Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects. Br J Pharmacol 91(4):735–745 Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC (2005) Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 126:73–81 Cetinel S, Hancioğlu S, Sener E, Uner C, Kiliç M, Sener G et al (2010) Oxytocin treatment alleviates stress-aggravated colitis by a receptor-dependent mechanism. Regul Pept 25(160):146–152 Dusunceli F, Iseri SO, Ercan F, Gedik N, Yegen C, Yegen BC (2008) Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides 29:1216–1222 Tuğtepe H, Sener G, Biyikli NK, Yüksel M, Cetinel S, Gedik N et al (2007) The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul Pept 140:101–108 Leyendecker G, Kunz G, Noe M, Herbertz M, Mall G (1998) Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 4(5):752–762 Kunz G, Noe M, Herbertz M, Leyendecker G (1998) Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update 4(5):647–654 Leyendecker G, Kunz G, Herbertz M, Beil D, Huppert P, Mall G et al (2004) Uterine peristaltic activity and the development of endometriosis. Ann N Y Acad Sci 1034:338–355 Salamanca A, Beltran E (1995) Subendometrial contractility in menstrual phase visualised by transvaginal sonography in patients with endometriosis. Fertil Steril 64:193–195 Bulun SE, Fang Z, Imir G, Gurates B, Tamura M, Yilmaz B et al (2004) Aromatase and endometriosis. Semin Reprod Med 22(1):45–50 Bilotas M, Meresman G, Stella I, Sueldo C, Barañao RI (2010) Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. Fertil Steril 15;93(8):2513–2518 Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS (2008) Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 115(7):818–822 Miyake A (1992) Roles of calcium ion in reproductive physiology. Acta Obstetrica et Gynaecologica Japonica 44(8):976–981 Gorczynska E, Handelsman DJ (1991) The role of calcium in follicle-stimulating hormone signal transduction in Sertoli cells. J Biol Chem 266(35):23739–23744 Morad F, Elsayed EM, Mahmoud SM (1997) Inhibition of steroid sex hormones release in rats by two Ca2+ channel blockers. Pharmacol Res 35(3):177–180 Acknowledgments This study has been presented as an oral presentation in 27th Annual Meeting of ESHRE - Stockholm 2011. Conflict of interest None. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Simsek, Y., Celik, O., Karaer, A. et al. Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis. Arch Gynecol Obstet 286, 777–783 (2012). https://doi.org/10.1007/s00404-012-2390-7 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-012-2390-7